SPDR STOXX Europe 600 SRI UCITS ETF EUR Acc is a equity ETF from SPDR tracking the STOXX Europe 600 SRI index through physical replication. Domiciled in Ireland and launched in 2019, the fund manages about 521 M € and charges a TER of 0.12% — 12 € per year on a €10,000 investment. Income is automatically reinvested in the fund (accumulating).
SPDR STOXX Europe 600 SRI UCITS ETF EUR Acc competes with 261 other products in the same class and region (Equity, Europe): it ranks 81st by fund size and 18th by ongoing cost, with a TER of 0.12% against a group median of 0.25%. It has been listed since 2019, 7 years of track record.
On a €10,000 investment the TER costs 12 € a year, against 25 € for the median product in the category.
Replication is physical: the fund holds the underlying securities directly. The ten largest positions account for 38.1% of the portfolio.
Income is accumulated: no distribution is paid out, the share price absorbs it. In a savings plan this removes the need to reinvest dividends by hand. The fund is denominated in EUR. That is not the same as currency risk: the exposure comes from the currencies of the underlying holdings, not from the denomination or the trading currency of a given listing.
The fund is domiciled in Ireland, which determines the tax treatment of income received by the fund and the supervisory authority.
| ASML Holding N.V. | 10.4% |
| Novartis AG | 4.1% |
| AstraZeneca PLC | 4.0% |
| Roche Holding AG | 4.0% |
| Nestle S.A. | 3.7% |
| Banco Santander S.A. | 2.8% |
| Schneider Electric S.E. | 2.6% |
| ABB Ltd | 2.3% |
| SAP SE | 2.1% |
| Novo Nordisk A/S | 2.1% |
| Borsa Italiana | 600X | EUR |
| XETRA | ZPDX | EUR |
| Francoforte | ZPDX | EUR |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.